Thymopoietin II: 32-35

Modify Date: 2025-08-22 16:17:05

Thymopoietin II: 32-35 Structure
Thymopoietin II: 32-35 structure
Common Name Thymopoietin II: 32-35
CAS Number 85466-18-8 Molecular Weight 516.59200
Density 1.45g/cm3 Boiling Point N/A
Molecular Formula C21H40N8O7 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Thymopoietin II: 32-35


Thymocartin (Thymopoietin II (32-35)) is the 32-35 fragment of the thymic factor (thymopoietin). Thymocartin has shown potential for immunodeficiency diseases research[1][2].

 Names

Name (2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid
Synonym More Synonyms

 Thymopoietin II: 32-35 Biological Activity

Description Thymocartin (Thymopoietin II (32-35)) is the 32-35 fragment of the thymic factor (thymopoietin). Thymocartin has shown potential for immunodeficiency diseases research[1][2].
Related Catalog
References

[1]. S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48(11):1190-6.  

[2]. Ch B Felder, et al. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters. J Microencapsul. 2003 Sep-Oct;20(5):553-67.  

 Chemical & Physical Properties

Density 1.45g/cm3
Molecular Formula C21H40N8O7
Molecular Weight 516.59200
Exact Mass 516.30200
PSA 275.84000
LogP 1.13990
Index of Refraction 1.619

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YV9384000
CHEMICAL NAME :
L-Valine, N-(N-(N(sup 2)-L-arginyl-L-lysyl)-L-alpha-aspartyl)-
CAS REGISTRY NUMBER :
85466-18-8
LAST UPDATED :
199410
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C21-H40-N8-O7
MOLECULAR WEIGHT :
516.69

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986

 Synonyms

Rgh 0206
Thymocartina [INN-Spanish]
Thymocartine [INN-French]
Thymocartinum [INN-Latin]
Thymocartina
Thymocartin
Thymopoietin II: 32-35
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Thymopoietin II: 32-35 suppliers

Thymopoietin II: 32-35 price

Related Compounds: More...
Thymopoietin II: 32-34
85465-82-3
BETA-AMYLOID (32-35)
151151-30-3
1,6,11,18,32,35,42,56-octa-(pentafluoroethyl)-[60]fullerene
1001320-43-9
1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-tridecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]tridecane
1072-41-9
2,21-dithia-7,10,13,16,26,29,32,35-octaazaheptacyclo[34.2.2.2~3,6~.2~10,13~.2~17,20~.2~22,25~.2~29,32~]pentaconta-1(38),3,5,17,19,22,24,36,39,43,45,49-dodecaene-8,15,27,34-tetrone 2,2,21,21-tetraoxide
6266-83-7
2,5,8,11,14,17,20,23,26,29,32,35-Dodecaoxaheptatriacontan-37-amine
869718-87-6
2,5,8,11,14,17,20,23,26,29,32,35,38-Tridecaoxahentetracontan-41-oic acid
2170098-33-4
2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53-Octadecaoxapentapentacontan-55-ol
171286-86-5
Propargyl-PEG17-methane
146185-77-5
methyl 1-(2-chlorophenyl)-3-methyl-1H-pyrazole-4-carboxylate
1186538-94-2
cyclohexyl[3-ethyl-1-(4-methoxyphenyl)-1H-pyrazol-4-yl]methanol
1186538-53-3
methyl 3-(methoxymethyl)-1-(3-methoxyphenyl)-1H-pyrazole-4-carboxylate
1186539-08-1
6-Chloro-5-methyl-3-(phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
916764-97-1
ethyl 1-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxylate
1186538-98-6
cyclohexyl[1-(3-chlorophenyl)-3-methyl-1H-pyrazol-4-yl]methanol
1186538-87-3
(4-Methyl-6-morpholin-4-yl-5-nitro-pyrimidin-2-yl)-(tetrahydro-pyran-4-ylmethyl)-amine
1242158-47-9
2-(1,4-dioxaspiro[4.5]dec-8-yloxy)-5-ethyl-Pyrimidine
1361391-13-0
3-[Chloro(cyclohexyl)methyl]-2-ethyl-1-benzofuran
1186540-16-8
3-(4-(Benzyloxy)cyclohexyloxy)-6-(4-(methylsulfonyl)piperazin-1-yl)pyridazine
1361392-13-3